Qiagen (Nasdaq: QGEN) reported earnings on Nov. 5. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended Sep. 30 (Q3), Qiagen met expectations on revenues and met expectations on earnings per share.

Compared to the prior-year quarter, revenue expanded and GAAP earnings per share dropped significantly.

Gross margins expanded, operating margins shrank, net margins dropped.

Revenue details
Qiagen chalked up revenue of $304.3 million. The 18 analysts polled by S&P Capital IQ wanted to see revenue of $304.7 million on the same basis. GAAP reported sales were 5.3% higher than the prior-year quarter's $288.9 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $0.26. The 14 earnings estimates compiled by S&P Capital IQ predicted $0.26 per share. GAAP EPS of $0.12 for Q3 were 20% lower than the prior-year quarter's $0.15 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 65.4%, 50 basis points better than the prior-year quarter. Operating margin was 12.8%, 160 basis points worse than the prior-year quarter. Net margin was 9.6%, 260 basis points worse than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $328.2 million. On the bottom line, the average EPS estimate is $0.31.

Next year's average estimate for revenue is $1.24 billion. The average EPS estimate is $1.04.

Investor sentiment
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 110 members out of 121 rating the stock outperform, and 11 members rating it underperform. Among 36 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 33 give Qiagen a green thumbs-up, and three give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Qiagen is hold, with an average price target of $17.67.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.